Article Details

CureVac's mRNA vaccine reaches an efficacy level of just 47 percent in a clinical trial.

Retrieved on: 2021-06-16 20:45:49

Tags for this article:

Click the tags to see associated articles and topics

CureVac's mRNA vaccine reaches an efficacy level of just 47 percent in a clinical trial.. View article details on hiswai:

Excerpt

Haas blamed the disappointing results on the high number of virus variants in the countries where the vaccine was tested. Out of 124 of the Covid-19 ...

Article found on: www.nytimes.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up